Klin Padiatr 2022; 234(03): 180
DOI: 10.1055/s-0042-1748704
Abstracts

A new inherited syndrome with severe neutropenia and neurological involvement due to autosomal recessive COPZ1 mutation

N Borbarán-Bravo
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
,
E Deordieva
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
2   Dmitry Rogachev National Research Center of pediatric Hematology, Oncology and Immunology, Moscow, Russia
,
S Bräuning
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
,
B Dannenmann
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
,
L Doll
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
,
M ElGamacy
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
3   Max Planck Institute for Developmental Biology, Tübingen, Germany
4   Friedrich Miescher Laboratory of the Max Planck Society Tübingen, Germany
,
C Zeidler
5   Department of Pediatric Hematology/Oncology, Klinderklinik, Hannover, Germany
,
B Bajoghly
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
,
A Maschan
2   Dmitry Rogachev National Research Center of pediatric Hematology, Oncology and Immunology, Moscow, Russia
,
A Shcherbina
2   Dmitry Rogachev National Research Center of pediatric Hematology, Oncology and Immunology, Moscow, Russia
,
K Welte
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
,
J Skokowa
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
,
M Klimiankou
1   University Hospital Tübingen, Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Germany
› Author Affiliations
 

We identified a new homozygous stop-codon mutation in the COPZ1 gene (p.Q141X) in two siblings with severe neutropenia and neurological developmental delay. COPZ1 is a member of the coatomer protein complex I (COPI) regulating intracellular trafficking of proteins.

CRISPR/Cas9-mediated introduction of the stop-codon mutation at the position p.Q141X in COPZ1 in healthy donors` cord blood hematopoietic stem cells (HSPCs) and iPSCs led to defective granulocytic differentiation in vitro. Additionally, copz1 mutant zebrafish embryos produced significantly fewer neutrophils than their control counterparts. These findings were in line with hyperactivated unfolded protein response (UPR) and elevated autophagy in the myeloid cell line NB4 after introduction of the truncated mutation in COPZ1.

COPZ1 is ubiquitously expressed, while its paralogous gene, COPZ2, is absent in the blood and the brain. Interestingly, the rescue of COPZ1 mutated HSPCs with COPZ2 corrected the defective granulopoiesis.

Thus, we describe a new severe congenital neutropenia syndrome caused by autosomal recessive COPZ1 mutations with downstream UPR and autophagy activation.



Publication History

Article published online:
17 May 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany